Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component C3 convertase is a central enzyme complex in the complement system. It catalyzes the cleavage of complement protein C3 into C3a and C3b, leading to opsonization, inflammation, and further activation of the complement cascade. There are two main forms: C4b2a (classical/lectin pathway) and C3bBb (alternative pathway). Its activity is tightly regulated to prevent excessive complement activation.
Inhibition of C3 convertase activity, Stabilization of C3 convertase, Promoting dissociation/inactivation of C3 convertase
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement component C3 convertase (C3 convertase).